Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hany Ezzeldin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Colorectal Cancer|September 21, 2004
Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administrationHany Ezzeldin, Robert Diasio
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapyAdam Lee, Hany Ezzeldin, Jeanne Fourie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Denaturing high performance liquid chromatography analysis of the DPYD gene in patients with lethal 5-fluorouracil toxicityHany Ezzeldin, Martin R Johnson, Yoshihiro Okamoto, et al.
Analytical Biochemistry|June 19, 2002
A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiencyHany Ezzeldin, Yoshihiro Okamoto, Martin R Johnson, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2006
Dihydropyrimidine dehydrogenase deficiency in an Indian populationMuhammad Wasif Saif, Lori Mattison, Tom Carollo, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2006
DPYD*2A mutation: the most common mutation associated with DPD deficiencyM W Saif, Hany Ezzeldin, Katisha Vance, et al.
Analytical Biochemistry|October 21, 2004
Simultaneous detection of variable number tandem repeats, single nucleotide polymorphisms, and allelic imbalance in the thymidylate synthase gene enhancer region using denaturing high-performance liquid chromatographyHany Ezzeldin, Cornelia Hoffmayer, Richie Soong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath testLori K Mattison, Hany Ezzeldin, Mark Carpenter, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 9, 2002
Electroretinographic abnormalities in parents of patients with Leber congenital amaurosis who have heterozygous GUCY2D mutationsRobert K Koenekoop, Gerald A Fishman, Alessandro Iannaccone, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Colorectal Cancer|September 21, 2004
Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administrationHany Ezzeldin, Robert Diasio
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapyAdam Lee, Hany Ezzeldin, Jeanne Fourie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Denaturing high performance liquid chromatography analysis of the DPYD gene in patients with lethal 5-fluorouracil toxicityHany Ezzeldin, Martin R Johnson, Yoshihiro Okamoto, et al.
Analytical Biochemistry|June 19, 2002
A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiencyHany Ezzeldin, Yoshihiro Okamoto, Martin R Johnson, et al.
Cancer Chemotherapy and Pharmacology|January 20, 2006
Dihydropyrimidine dehydrogenase deficiency in an Indian populationMuhammad Wasif Saif, Lori Mattison, Tom Carollo, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2006
DPYD*2A mutation: the most common mutation associated with DPD deficiencyM W Saif, Hany Ezzeldin, Katisha Vance, et al.
Analytical Biochemistry|October 21, 2004
Simultaneous detection of variable number tandem repeats, single nucleotide polymorphisms, and allelic imbalance in the thymidylate synthase gene enhancer region using denaturing high-performance liquid chromatographyHany Ezzeldin, Cornelia Hoffmayer, Richie Soong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath testLori K Mattison, Hany Ezzeldin, Mark Carpenter, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 9, 2002
Electroretinographic abnormalities in parents of patients with Leber congenital amaurosis who have heterozygous GUCY2D mutationsRobert K Koenekoop, Gerald A Fishman, Alessandro Iannaccone, et al.
Pageof 1